We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A 3D model of a human brain.

Hidden Brain Region May Unlock New Epilepsy Treatment

Cell therapy.

Cell Therapy Treatment Effectively Treats Immune-Compromised Children

A selection of diabetes monitoring and treatment neccessities.

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

Cannabinols Show Neuroprotective Properties in Fruit Flies

News

SGS Expands Biomarker Services at its Laboratory in Poitiers, France

Full analytical validation of Meso Scale Discovery (MSD®) V-PLEX 10-plex Proinflammatory Panel I.

AMRI Announces CFO Transition

Michael M. Nolan, senior vice president and chief financial officer, will be departing AMRI.

Biogen Idec Acquires Convergence Pharmaceuticals

Company to expand neuropathic pain portfolio with the acquisition.

Aptuit to Divest Two Non-Core Sites

AMRI to purchase Glasgow, UK and West Lafayette, Indiana, U.S.A. sites.

BioLineRx Announces Completion of Enrollment in CE Mark Registration Trial of BCM

PRESERVATION I trial completion anticipated in mid-2015.

Resverlogix Presents at Biotech Showcase During JP Morgan Week

Donald McCaffrey share developments of the Company's proposed new phase 3 clinical trial BETONMACE.

Vygon Group Expands into Singapore

French group Vygon opens a subsidiary in Singapore, strengthening its presence in Asia-Pacific.

First Contracting Human Muscle Grown in Laboratory

Researchers at Duke University report the first lab-grown, contracting human muscle, which could revolutionize drug discovery and personalized medicine.

BEYOND RESEARCH Initiative of 4SC Discovery and CRELUX Reaches First Milestone

Compounds for inhibiting oxygen radicals and associated signalling pathways optimized for developing innovative therapies for degenerative diseases.

MGB Biopharma Continues to Progress its Truly Novel Anti-Infectives Platform

Oral formulation of MGB-BP-3 for the treatment of Clostridium difficile infections on track to enter the clinic in Q2 2015.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter